HK1026718A1 - Attenuated forms of bovine viral diarrhea virus - Google Patents

Attenuated forms of bovine viral diarrhea virus

Info

Publication number
HK1026718A1
HK1026718A1 HK00105908A HK00105908A HK1026718A1 HK 1026718 A1 HK1026718 A1 HK 1026718A1 HK 00105908 A HK00105908 A HK 00105908A HK 00105908 A HK00105908 A HK 00105908A HK 1026718 A1 HK1026718 A1 HK 1026718A1
Authority
HK
Hong Kong
Prior art keywords
diarrhea virus
bovine viral
viral diarrhea
attenuated forms
attenuated
Prior art date
Application number
HK00105908A
Other languages
English (en)
Inventor
Xue Mei Cao
M G Steppard
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HK1026718A1 publication Critical patent/HK1026718A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HK00105908A 1998-11-10 2000-09-20 Attenuated forms of bovine viral diarrhea virus HK1026718A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10790898P 1998-11-10 1998-11-10

Publications (1)

Publication Number Publication Date
HK1026718A1 true HK1026718A1 (en) 2000-12-22

Family

ID=22319107

Family Applications (2)

Application Number Title Priority Date Filing Date
HK00105908A HK1026718A1 (en) 1998-11-10 2000-09-20 Attenuated forms of bovine viral diarrhea virus
HK04110338A HK1067383A1 (en) 1998-11-10 2004-12-30 Attenuated forms of bovine viral diarrhea virus

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK04110338A HK1067383A1 (en) 1998-11-10 2004-12-30 Attenuated forms of bovine viral diarrhea virus

Country Status (12)

Country Link
US (4) US6168942B1 (xx)
EP (1) EP1013757A3 (xx)
JP (2) JP3602759B2 (xx)
CN (2) CN1247775C (xx)
AR (1) AR019250A1 (xx)
AU (1) AU765792B2 (xx)
BR (1) BR9905352A (xx)
CA (1) CA2287775A1 (xx)
HK (2) HK1026718A1 (xx)
NZ (1) NZ500925A (xx)
TW (1) TW585916B (xx)
ZA (1) ZA997011B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) * 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
EP1035205A1 (en) * 1999-03-08 2000-09-13 Stichting Dienst Landbouwkundig Onderzoek Non-spreading pestivirus
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US20040229224A1 (en) * 2003-05-13 2004-11-18 Perlegen Sciences, Inc. Allele-specific expression patterns
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
DE102004025452A1 (de) * 2004-05-19 2006-01-19 Boehringer Ingelheim Vetmedica Gmbh Vakzine enthaltend BVDV
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
AU2006323028B2 (en) * 2005-12-07 2010-02-25 Zoetis P Llc Marked bovine viral diarrhea virus vaccines
WO2008034857A1 (en) 2006-09-22 2008-03-27 Intervet International B.V. Pestivirus mutant for use in a vaccine
EP2130912A1 (en) * 2008-06-04 2009-12-09 Institut für Viruskrankeiten und Immunprophylaxe Pestivirus replicons providing an RNA-based viral vector system
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
WO2012038454A1 (en) 2010-09-21 2012-03-29 Intervet International B.V. Bvdv vaccine
RU2502522C1 (ru) * 2012-07-27 2013-12-27 Государственное научное учреждение Всероссийский научно-исследовательский институт ветеринарной санитарии, гигиены и экологии Российской академии сельскохозяйственных наук Способ получения вакцины против вирусной диареи крупного рогатого скота
CN113174374B (zh) * 2021-05-19 2022-07-22 西南民族大学 一种牛病毒性腹泻病毒弱毒株及其用途
CN113403256B (zh) * 2021-06-16 2023-04-18 中国农业科学院特产研究所 一种稳定产生牛病毒性腹泻病毒抗原的细胞系及抗体胶体金检测试纸条的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687769T2 (de) 1985-07-08 1993-09-02 Wallone Region Vakzine und diagnostika, die vom bovine-diarrhea-virus stammen.
US5206163A (en) * 1985-07-08 1993-04-27 Chiron Corporation DNA encoding bovine diarrhea virus protein
FR2677767B1 (fr) 1991-06-11 1994-10-14 Biotechnologie Ste Europeenne Procede de detection de l'infection par le virus de la diarrhee bovine, sequence nucleotidique codant pour une proteine induite par l'infection par ce virus et proteines et antigenes recombinants s'y rapportant .
EP1104676A1 (en) 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows

Also Published As

Publication number Publication date
JP3602841B2 (ja) 2004-12-15
JP2000139482A (ja) 2000-05-23
US20030165520A1 (en) 2003-09-04
TW585916B (en) 2004-05-01
CA2287775A1 (en) 2000-05-10
EP1013757A2 (en) 2000-06-28
JP2003259885A (ja) 2003-09-16
US6410299B1 (en) 2002-06-25
AU765792B2 (en) 2003-10-02
CN1510130A (zh) 2004-07-07
AR019250A1 (es) 2001-12-26
NZ500925A (en) 2001-06-29
ZA997011B (en) 2001-05-09
CN1254756A (zh) 2000-05-31
BR9905352A (pt) 2001-02-06
AU5837699A (en) 2000-05-11
HK1067383A1 (en) 2005-04-08
US6410032B1 (en) 2002-06-25
CN1247775C (zh) 2006-03-29
JP3602759B2 (ja) 2004-12-15
US6916477B2 (en) 2005-07-12
US6168942B1 (en) 2001-01-02
EP1013757A3 (en) 2002-03-06
CN1231578C (zh) 2005-12-14

Similar Documents

Publication Publication Date Title
HK1026718A1 (en) Attenuated forms of bovine viral diarrhea virus
HUP0103908A3 (en) Novel infulenza virus vaccine composition
HK1097413A1 (en) Compositions comprising viruses and methods for concentrating virus preparations
IL135026A0 (en) Improved gunsight and reticle therefor
GB9811433D0 (en) Virus vaccine
EP0759072A4 (en) RECOMBINATION PRODUCTS OF POXVIRUS AND DOG SQUARE VIRUS (CDV) AND COMPOSITIONS AND METHODS USING THE SAME
EP0759979A4 (en) ANTISENSE OLIGONUCLEOTIDES INHIBITION OF HEPATITIS C VIRUS
EP0939835A4 (en) COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS
GB9415369D0 (en) Mutant virus
EP0973924A4 (en) RECOMBINANT CHIMERAL VIRUSES AND THEIR USE
ZA9811316B (en) Novel hepatitis C virus NS5B protein
AU3714499A (en) Hepatitis c virus mimotopes
EP1135137A4 (en) COPOLYMER COMPOSITIONS FOR TREATING VIRAL INFECTIONS
HU9800113D0 (en) Transgenic virus
GB9809666D0 (en) Modified viruses
EP0745133A4 (en) RECOMBINANT BOVINE INFECTIOUS RHINOTRACHEITIS VIRUS S-IBR-052 AND USES THEREOF
GB9704575D0 (en) Recombinant HCMV helicase
ZA985117B (en) Method of attenuating viruses.
HUP0003511A3 (en) Hepatitis b virus polypeptides
GB2351904B (en) Herbal composition and use of the composition for treating viral infection of the liver
GB9804293D0 (en) Plant virus promoter and detection
HUP0003971A2 (en) Compact epstein-barr virus replicons
AU3118100A (en) Vectors having terminal repeat sequence of epstein-barr virus
EP0646373A3 (en) Epstein-Barr virus expression inhibitor.
GB9420956D0 (en) Virus

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091110